MADISON, N.J., March 23 /PRNewswire-FirstCall/ -- Wyeth announced today that the jury in the cases of Suzan Talbot v. Wyeth, Sharon Thacker v. Wyeth, Ernestine Vigil v. Wyeth and Jorie Williams v. Wyeth in the Philadelphia Court of Common Pleas rendered a decision in the first phase of the trial. During the first part of this bifurcated (two-phase) trial, the jury awarded $109,100 to Ms. Talbot, $88,700 to Ms. Thacker, $90,400 to Ms. Vigil and $104,000 to Ms. Williams. The second phase of this case is scheduled to begin on March 27.
“We are disappointed in the jury’s verdict in this case and believe it was not supported by the evidence presented. In each instance, the only physicians claiming that the plaintiffs have an injury were hired by their lawyers,” says Mike Scott of Reed Smith, the attorney representing Wyeth. “In the second phase of this case, we will show that Wyeth acted responsibly at all times and should not be held liable for any award to these plaintiffs.”
The trial began on March 13, 2006 before The Honorable James Murray Lynn. Of the five plaintiffs who were originally included in this trial group, one plaintiff voluntarily dismissed his case before trial.
Wyeth is one of the world’s largest research-driven pharmaceutical and health care products companies. It is a leader in the discovery, development, manufacturing, and marketing of pharmaceuticals, vaccines, biotechnology products and nonprescription medicines that improve the quality of life for people worldwide. The Company’s major divisions include Wyeth Pharmaceuticals, Wyeth Consumer Healthcare and Fort Dodge Animal Health.
Wyeth
CONTACT: Media: Douglas Petkus, +1-973-660-5218; or Investors: JustinVictoria, +1-973-660-5340, both of Wyeth
Web site: http://www.wyeth.com/
